# A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Children

> **NCT05111431** · PHASE3 · COMPLETED · sponsor: **Shanghai Hengrui Pharmaceutical Co., Ltd.** · enrollment: 159 (actual)

## Conditions studied

- Preoperative Sedation of Children

## Interventions

- **DRUG:** Dexmedetomidine Hydrochloride Nasal Spray
- **DRUG:** Dexmedetomidine hydrochloride nasal spray blank preparation

## Key facts

- **NCT ID:** NCT05111431
- **Lead sponsor:** Shanghai Hengrui Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-24
- **Primary completion:** 2022-05-20
- **Final completion:** 2022-05-20
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2022-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05111431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05111431, "A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05111431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*